Ledger.Open graph →
SEC Form D · Amendment · filed August 12, 2019

Palvella Therapeutics, Inc

Offering
$5.0M
Sold
$4.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WAYNE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Kerrie H. Brady · Boston, MADirectorEric D. Chin · San Carlos, CADirectorAntonios T. Valamontes · Largo, FLExec · DirectorTom Broussard · Boston, MADirectorJames J. Cunnane, Jr · St. Louis, MODirectorBrandon Alexander · San Carlos, CADirectorJohn T. Karantonis · Norridge, ILDirectorMichael Konnert · VANCOUVER, British Columbia, CanadaExec · DirectorCraig Parry · VANCOUVER, British Columbia, CanadaDirectorCharles Funk · VANCOUVER, British Columbia, CanadaDirectorKimberley Yates · Redwood City, CADirectorAlan Hartman · Redwood City, CADirectorMichael Kaplan · Redwood City, CADirectorShawn Anderson · Idaho Falls, IDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗